📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-17 22:52
510 analysed today
510
Today
133,399
All-time analysed
40,108
Positive
6,279
Negative
79,197
Neutral
7,747
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
33 announcements match the current filters (relevance ≥ 5).
Mastek Concludes Chennai Commercial Property Sale for ₹60 Cr
Mastek Limited has completed the sale of its commercial building comprising approximately 1,57,233 sq. ft. on 15.50 acres of leased land at Mahindra World City SEZ, Chennai. The company received total cash consideration of ₹60 crore in two tranches from buyer Caresoft Mobility Private Limited. The transaction was finalized on August 17, 2026, at arm's length with an unrelated party. The ₹60 crore consideration represents ~6.9% of Mastek's net worth (₹868 crore) and unlocks capital from non-core real estate.
Confidence: HIGH
What changedMastek has fully executed and completed the sale of its Chennai SEZ commercial property to Caresoft Mobility for ₹60 crore.
Why it mattersThe sale monetizes non-core physical real estate, adding ₹60 crore (~6.9% of net worth) in liquidity without affecting core software delivery operations.
Total consideration: Rs. 60 croresConsideration vs Net worth: ~6.9%Built-up area: 1,57,233 Sq. Ft.Leased land area: 15.50 acresCompletion date: August 17, 2026
📅 Short termMay reflect as an exceptional item/one-off cash inflow in Q2 FY27 earnings, slightly boosting cash reserves.
📈 Long termLimited structural impact on core IT consulting business; aligns with maintaining an asset-light balance sheet.
Key Highlights
Received aggregate consideration of ₹60 crore in two tranches
Sold commercial building of ~1,57,233 sq. ft. on 15.50 acres of leased SEZ land in Chennai
Sale completed on August 17, 2026, following the MoU dated April 24, 2026
Buyer identified as Caresoft Mobility Private Limited (non-promoter / unrelated entity)
👀 What to Watch
Track the upcoming quarterly financial results for any one-time exceptional gain or loss recognized from this asset disposal and how the cash proceeds are redeployed.
₹16 Final Dividend: Mastek Sets August 31, 2026, as Record Date
Mastek Limited has fixed August 31, 2026, as the record date to determine eligibility for a final dividend of ₹16 per equity share for FY25-26. This dividend was previously recommended by the Board on April 17, 2026, and is subject to shareholder approval at the 44th Annual General Meeting (AGM) on September 7, 2026. Based on the TTM EPS of ₹130.42, this represents a payout ratio of approximately 12.3%. The dividend yield at the current price of ₹1812.6 is approximately 0.88%.
Confidence: HIGH
What changedThe company has officially scheduled its 44th AGM and finalized the record date for the final dividend recommended earlier in April 2026.
Why it mattersThis is a routine capital allocation event, providing a cash return to shareholders. The payout is well-covered by the company's annual net profit of ₹403.2 Cr (FY26).
Final Dividend: ₹16 per shareRecord Date: August 31, 2026Dividend Yield: ~0.88%Payout vs TTM EPS: ~12.3%AGM Date: September 7, 2026
📅 Short termThe stock price may see a minor adjustment on the ex-dividend date (typically one business day prior to the record date) reflecting the ₹16 payout.
📈 Long termLimited; this is a routine procedural filing for a scheduled dividend payment.
Key Highlights
Final dividend of ₹16 per equity share with a face value of ₹5 each.
Record date for dividend eligibility is Monday, August 31, 2026.
44th Annual General Meeting (AGM) scheduled for September 7, 2026.
Dividend payment to be processed within 30 days of shareholder approval at the AGM.
TTM PAT of ₹403 Cr supports the total dividend outflow.
👀 What to Watch
Investors should note the record date of August 31, 2026; shares must be held in the demat account by this date to receive the ₹16 dividend. Monitor the AGM outcomes on September 7 for formal approval.
₹16 Final Dividend: Mastek Sets August 31 as Record Date for FY26
Mastek Limited has scheduled its 44th Annual General Meeting (AGM) for September 7, 2026, via video conferencing. The company has fixed August 31, 2026, as the record date to determine eligibility for a final dividend of ₹16 per equity share (face value ₹5). This dividend, recommended by the board in April 2026, represents a yield of approximately 0.88% against the current market price of ₹1812.6. Payment is expected within 30 days following shareholder approval at the AGM.
Confidence: HIGH
What changedThe company has finalized the administrative timeline for its annual shareholder meeting and the distribution of the previously recommended final dividend.
Why it mattersThis is a routine corporate action that confirms the distribution of profits to shareholders; the ₹16 dividend is part of the total payout for a year where PAT grew to ₹403.2 Cr.
Final Dividend: ₹16 per shareRecord Date: August 31, 2026AGM Date: September 07, 2026Dividend Yield: ~0.88%Face Value: ₹5
📅 Short termThe stock price may adjust by the dividend amount on the ex-dividend date. No significant price volatility is expected from this routine announcement.
📈 Long termLimited; this is a routine annual event. The long-term focus remains on Mastek's ability to diversify revenue away from the UK public sector and grow its US market share.
Key Highlights
Final dividend of ₹16 per equity share of ₹5 each recommended for FY 2025-26.
Record date for dividend entitlement fixed as Monday, August 31, 2026.
44th Annual General Meeting scheduled for Monday, September 07, 2026, at 5:00 PM IST.
Dividend payment to be completed within 30 days from the date of shareholder approval.
👀 What to Watch
Investors seeking the dividend must hold the stock before the ex-dividend date (typically one business day prior to the August 31 record date). Monitor the AGM proceedings for management updates on the 12-month order backlog, which was last reported at ₹2,067.6 Cr.
Mastek Signs Platinum Partnership with Innovaccer for AI Healthcare across 4 Global Regions
Mastek has entered a strategic Platinum Partnership with Innovaccer to implement the 'Gravity' healthcare intelligence platform globally. The partnership targets healthcare organizations in North America, UK, Europe, and the Middle East, focusing on AI-driven data unification. This move aligns with Mastek's strategy to diversify its revenue base, which currently sees over 50% concentration in the UK Public/Healthcare sectors. While no specific contract value was disclosed, the partnership leverages Mastek's 5,000-strong workforce and 400+ active customer base to scale AI transformation.
Confidence: HIGH
What changedMastek has formalized a high-tier global partnership with Innovaccer, moving from a general service provider to a specialized implementation partner for AI-driven healthcare platforms.
Why it mattersHealthcare is a critical vertical for Mastek, with the UK NHS being a major client; this partnership provides a structured path to expand into the US healthcare market and reduce UK dependency.
TTM Revenue: ₹3699 CrUS Revenue Share (FY24): 27.2%Workforce: 5,000 employeesActive Customers: 400+
📅 Short termThe announcement is sentiment-positive as it reinforces Mastek's 'AI-first' positioning and strategic focus on the high-growth healthcare vertical.
📈 Long termIf executed well, this partnership could structurally improve Mastek's margins and geographic mix by capturing higher-value AI transformation projects in the US and Middle East.
⚠ Risk flags
- Execution risk in scaling a third-party platform
- Intense competition in the US healthcare IT market
- No immediate quantified order value
Key Highlights
Achieved Platinum Global Partner status for Innovaccer’s Gravity Platform for autonomous healthcare operations.
Partnership covers 4 major geographic regions: North America, UK, Europe, and the Middle East.
Mastek utilizes a workforce of nearly 5,000 employees to support its AI-first digital engineering approach.
The company currently manages a portfolio of 400+ active customers across 40 countries.
Strategic focus on increasing US revenue contribution, which stood at 27.2% in FY24.
👀 What to Watch
Monitor the conversion of this partnership into tangible order wins in the US healthcare sector in upcoming quarterly results to validate the company's geographic diversification strategy.
Mastek Q1 FY27: 25% YoY Order Backlog Growth and $25M AI Deal in North America
Mastek reported a steady Q1 FY27 with revenue reaching $104.8 million, a 1.2% sequential increase in USD terms. The 12-month order backlog showed strong momentum, growing 25% YoY (13% in constant currency), providing significant revenue visibility. A key highlight was a $25 million AI transformation deal in North America, the largest in recent quarters, helping offset headwinds in the Middle East. Management is pivoting the company toward an 'AI transformation' focus, supported by the appointment of a new COO from LTIMindtree.
Confidence: HIGH
What changedMastek is transitioning from a traditional engineering services provider to an AI-led transformation company, evidenced by a major $25M AI deal and internal AI-led process automation.
Why it mattersThe 25% backlog growth provides strong revenue visibility for the next 12 months. The shift toward AI-led deals is critical to maintaining competitiveness and protecting margins against pricing pressures in legacy services.
Q1 Revenue: $104.8 million12-Month Order Backlog Growth (YoY): 25%Large AI Deal Value: $25 millionDeal vs TTM Revenue: ~5.6%Operating EBITDA Margin: 15.4%UK Constant Currency Growth (QoQ): 3%
📅 Short termThe stock may see positive sentiment driven by the strong backlog and the large $25M deal win, though Middle East volatility remains a minor drag.
📈 Long termThe structural pivot to AI and increasing US market share (currently ~27%) are key to long-term growth and reducing dependency on UK public sector spending.
⚠ Risk flags
- Geopolitical volatility in the Middle East impacting regional revenue
- AI-led competition challenging incumbents in existing accounts
- UK government policy/budget changes following leadership transition
Key Highlights
12-month order backlog grew 25% YoY in reported terms and 13% in constant currency
Secured a $25 million AI transformation deal in North America involving Salesforce Agentforce
Closed 40-plus new AI-led opportunities during the quarter
UK business, representing over 50% of revenue, grew 3% QoQ in constant currency
Operating EBITDA margin maintained at 15.4% for the quarter
👀 What to Watch
Monitor the execution timeline of the $25 million North America deal and the impact of the new COO on delivery efficiency. Watch for stabilization in the Middle East business and any budget shifts from the new UK government.
25% YoY Order Backlog Growth to Rs 2,935 Cr; Q1 Revenue Up 5% QoQ
Mastek reported a resilient Q1FY27 with revenue reaching Rs 985.3 crore, a 5% sequential growth. The 12-month order backlog grew significantly by 25% YoY to Rs 2,935.2 crore, representing approximately 79% of TTM revenue, which provides strong visibility. While EBITDA margins contracted slightly to 15.4% due to Middle East collection delays, the company secured major AI-led wins, including a $25 million deal in North America. Cash reserves improved to Rs 945.4 crore, strengthening the balance sheet for future growth.
Confidence: HIGH
What changedMastek has pivoted its strategy to 'Lead with AI', with AI deals now making up nearly half of new orders, and has achieved a record order backlog of nearly Rs 3,000 crore.
Why it mattersThe high order backlog (79% of TTM revenue) provides high revenue predictability, while the shift to AI-led services helps maintain competitive relevance and supports the company's goal of geographic diversification into the US market.
Q1FY27 Revenue: Rs 985.3 crOrder Backlog vs TTM Revenue: 79.3%EBITDA Margin: 15.4%Cash and Investments: Rs 945.4 crNew AI Deal Share: 45%
📅 Short termPositive sentiment is expected due to strong order booking and sequential revenue growth in key markets like the UK and US, despite minor margin pressure.
📈 Long termThe structural shift towards AI and cloud transformation, coupled with a robust cash position and reducing UK dependency, positions the company for steady long-term growth.
⚠ Risk flags
- Geopolitical uncertainty in the Middle East impacting collections and margins
- High concentration in UK public sector and healthcare
- Pricing pressures from global IT peers
Key Highlights
12-month order backlog reached Rs 2,935.2 crore, a 25% YoY increase in rupee terms.
Revenue from operations grew 5.0% QoQ to Rs 985.3 crore, with 1.8% growth in constant currency.
AI-led deals now contribute approximately 45% of the new order book, including a $25 million Salesforce deal in North America.
Cash and investment position strengthened to Rs 945.4 crore, adding ~Rs 200 crore over the last two quarters.
Attrition rate improved, declining by 1% YoY to 16.4% with a total headcount of 4,897.
👀 What to Watch
Monitor the conversion of the record order backlog into revenue and the stabilization of margins, particularly in the Middle East business which is facing geopolitical headwinds. Watch for the execution of the $25 million North American deal as a benchmark for AI-led growth.
Rs 985.3 Cr Q1 Revenue; 12-Month Order Backlog Grows 25% YoY to Rs 2,935 Cr
Mastek reported a 5.0% QoQ revenue growth to Rs 985.3 Cr for Q1FY27, supported by a strong 6.2% sequential growth in the North American market. The 12-month order backlog reached a record Rs 2,935.2 Cr, representing approximately 79.3% of TTM revenue, providing high visibility. While Net Profit grew 15% YoY to Rs 105.9 Cr, EBITDA margins contracted by 71 bps QoQ to 15.4%, primarily due to collection delays in the Middle East business. Notably, AI-led deals now account for ~45% of the new order book, signaling a successful strategic shift.
Confidence: HIGH
What changedMastek has successfully pivoted to an AI-led strategy with nearly half of new orders being AI-driven, while simultaneously growing its order backlog to a record high despite geopolitical headwinds in the Middle East.
Why it mattersThe record order backlog (79% of TTM revenue) significantly de-risks future revenue, while the increasing contribution from the US market (6.2% growth) helps reduce the company's historical over-reliance on UK public sector spending.
Q1 Revenue: Rs 985.3 Cr12-Month Order Backlog: Rs 2,935.2 CrBacklog vs TTM Revenue: 79.3%EBITDA Margin: 15.4%Net Profit (Q1): Rs 105.9 CrTotal Cash & Investments: Rs 945.4 Cr
📅 Short termThe strong order backlog and AI momentum are likely to be viewed positively by the market, though the slight margin compression and Middle East collection issues may limit immediate upside.
📈 Long termThe structural shift toward AI-native services and the expansion of the US Federal and Healthcare footprint position Mastek for higher-value digital transformation work over the next 2-3 years.
⚠ Risk flags
- Geopolitical uncertainty in the Middle East impacting collections and margins
- High concentration in UK Public/Healthcare sectors (>50% revenue)
- Pricing pressures from global IT peers
Key Highlights
12-month order backlog reached Rs 2,935.2 Cr ($310.1mn), a 25.0% increase YoY in rupee terms.
AI-led deals contributed approximately 45% of the new order book during Q1FY27.
Revenue from operations grew 5.0% QoQ to Rs 985.3 Cr, while constant currency growth stood at 1.8%.
Cash and investment position strengthened to Rs 945.4 Cr, an increase of ~Rs 200 Cr over the last two quarters.
North America and UK/Europe segments delivered sequential revenue growth of 6.2% and 6.5% respectively.
👀 What to Watch
Watch for the stabilization of margins in the Middle East business and the execution timeline of the $25mn AI-led Salesforce deal in North America. Investors should also monitor if the high order backlog translates into accelerated revenue growth in H2FY27.
Mastek Q1 FY27 Revenue up 7.7% YoY to ₹985.25 Cr; PBT Grows 14.7%
Mastek Limited reported a steady start to FY27 with revenue from operations reaching ₹985.25 Cr, a 5.0% sequential growth from the previous quarter. Profit Before Tax (PBT) stood at ₹138.46 Cr, reflecting a 14.7% increase compared to ₹120.70 Cr in the same quarter last year. Employee benefit expenses remain the primary cost driver at ₹532.56 Cr, accounting for approximately 54% of total revenue. The company also updated its fair disclosure code for price-sensitive information to align with regulatory standards.
Confidence: HIGH
What changedThe filing represents the release of Q1 FY27 financial results and an amendment to the company's internal code for fair disclosure of price-sensitive information.
Why it mattersThe results demonstrate Mastek's ability to maintain mid-single-digit sequential growth and improve profitability despite a challenging global IT environment and high concentration in the UK public sector.
Revenue (Q1 FY27): ₹985.25 CrRevenue vs TTM Revenue: ~26.6%PBT Growth (YoY): 14.7%Employee Cost to Revenue: 54.1%Other Income: ₹12.03 Cr
📅 Short termThe stock may see positive sentiment in the short term due to steady revenue growth and the absence of exceptional losses that impacted the previous quarter.
📈 Long termLong-term value depends on the successful integration of acquisitions like BizAnalytica and the ability to scale the US business beyond the current 27.2% revenue share.
⚠ Risk flags
- High employee cost concentration (54% of revenue)
- Significant revenue dependency on UK/Europe markets (~57%)
- Pricing pressures from global IT peers
Key Highlights
Revenue from operations increased 7.7% YoY to ₹985.25 Cr from ₹914.70 Cr in June 2025
Profit Before Tax (PBT) rose to ₹138.46 Cr, up from ₹120.70 Cr in the year-ago period
Employee benefit expenses grew to ₹532.56 Cr compared to ₹489.96 Cr in June 2025
Total income for the quarter reached ₹997.28 Cr, including other income of ₹12.03 Cr
The company reported zero exceptional losses this quarter, compared to a ₹23.73 Cr loss in the preceding quarter
👀 What to Watch
Investors should monitor the upcoming management commentary regarding the 12-month order backlog and the progress of US market expansion, which is a key strategic goal to reduce UK dependency.
Mastek Q1 FY27 Revenue up 7.7% YoY to ₹985.25 Cr; PBT Rises 14.7% YoY
Mastek reported a steady start to FY27 with Q1 revenue reaching ₹985.25 Cr, a 5.0% sequential growth from Q4 FY26. Profit Before Tax (PBT) stood at ₹138.46 Cr, up 14.7% YoY, benefiting from the absence of exceptional losses that impacted the previous quarter. Employee benefit expenses rose to ₹532.56 Cr, accounting for 54% of total revenue, while finance costs decreased slightly to ₹6.59 Cr. The company also updated its insider trading disclosure policies to align with regulatory standards.
Confidence: HIGH
What changedMastek reported its Q1 FY27 financial results showing steady growth and updated its Fair Disclosure Code for Unpublished Price Sensitive Information (UPSI).
Why it mattersThe results demonstrate consistent top-line growth and margin resilience despite rising employee costs; the absence of exceptional items improves the quality of earnings compared to the previous quarter.
Revenue (Q1 FY27): ₹985.25 CrRevenue Growth (YoY): 7.7%PBT (Q1 FY27): ₹138.46 CrEmployee Cost as % of Revenue: 54.0%Quarterly Revenue vs TTM Revenue: ~26.6%
📅 Short termThe stock may see positive sentiment due to steady sequential revenue growth and improved PBT margins following a quarter with exceptional losses.
📈 Long termStructural growth depends on the successful integration of BizAnalytica and MST Solutions to drive US market share beyond the current 27.2% and mitigate UK public sector concentration risks.
⚠ Risk flags
- High concentration in UK Public/Healthcare sectors (>50% revenue)
- Rising employee benefit expenses impacting operating leverage
- Currency volatility (GBP/INR) affecting margins
Key Highlights
Revenue from operations grew 7.7% YoY to ₹985.25 Cr from ₹914.70 Cr in June 2025
Profit Before Tax (PBT) increased 14.7% YoY to ₹138.46 Cr
Employee benefit expenses rose 5.9% QoQ to ₹532.56 Cr, reflecting talent acquisition costs
Other income declined to ₹12.03 Cr from ₹23.87 Cr in the preceding quarter
Zero exceptional items reported this quarter compared to a ₹23.73 Cr loss in Q4 FY26
👀 What to Watch
Monitor the 12-month order backlog (previously ₹2,067.6 Cr) and the pace of US market revenue contribution, which is critical for reducing the current 57% dependency on the UK/Europe market.
10M Tonne Operations: Mastek Partners with Yanbu Cement for Digital Transformation
Mastek has entered into a strategic partnership with Yanbu Cement Company (YCC), a major Saudi Arabian cement manufacturer, to modernize its production-to-dispatch operations. The project involves digitizing a facility that handles over 10 million tonnes of cement and 220,000 truck movements annually. While the specific contract value was not disclosed, the implementation utilizes Oracle Fusion Cloud ERP and Industrial IoT to automate mission-critical workloads. This deal reinforces Mastek's strategy to expand its footprint in the Middle East and leverage its Oracle Cloud expertise.
Confidence: HIGH
What changedMastek has secured a high-profile industrial IoT and ERP integration contract with a leading Saudi cement manufacturer, moving beyond traditional IT services into heavy industry automation.
Why it mattersThe partnership demonstrates Mastek's ability to execute complex 'Industry 4.0' projects in the Middle East, a key growth market for diversifying revenue away from its heavy UK public sector dependency (currently >50%).
YCC Annual Cement Dispatch: 10 million tonnesAnnual Truck Movements: 220,000Truck Turnaround Improvement: 2xMastek TTM Revenue: Rs 3699 CrContract Value: not disclosed
📅 Short termThe announcement is likely to be viewed positively as it validates Mastek's 'Lead with AI' and IoT capabilities in a competitive international market.
📈 Long termIf successfully scaled, such industrial partnerships could improve Mastek's operating margins (currently 15.8%) by shifting the mix toward higher-value digital engineering and IoT solutions.
⚠ Risk flags
- Lack of disclosed contract value
- Execution risks in complex IoT-ERP integration
- Geopolitical/regional concentration in the Middle East
Key Highlights
Modernizing operations for a plant with over 10 million tonnes of annual cement dispatch
Managing digital infrastructure for approximately 220,000 truck movements per year
Reported a 2x improvement in truck turnaround time through automation and digital validation
Integration of Oracle Fusion Cloud ERP with IoT-enabled weighbridges and GPS-driven transit tracking
Project aligns with Saudi Arabia’s Vision 2030 and Industry 4.0 digital transformation agenda
👀 What to Watch
Investors should monitor the AMEA (Asia, Middle East, Africa) region's revenue growth in upcoming quarterly filings to assess the financial scale of such industrial digital transformation contracts.
Mastek Receives ₹123.58 Crore Income Tax Assessment Order; Company to Appeal
Mastek Limited has received a Final Assessment Order from the Income Tax Department for FY 2022-23, involving a total income addition of ₹123.58 crore. The order includes a transfer pricing adjustment of ₹90.95 crore and domestic tax additions of ₹32.63 crore, alongside initiated penalty proceedings. The company has identified several computation errors in the order, such as incorrect tax rates and the non-allowance of foreign tax credits. Mastek intends to contest the order before the Income Tax Appellate Authorities and currently expects no material financial impact.
Key Highlights
Total income addition of ₹1,23,58,26,194 (approx. ₹123.58 crore) for FY 2022-23.
Transfer pricing adjustments account for ₹90.95 crore of the total addition.
Penalty proceedings have been initiated under Section 270A of the Income Tax Act.
Company claims significant computation errors, including non-grant of credit for advance tax paid by an amalgamated subsidiary.
Mastek plans to file objections/responses with the Income Tax Appellate Authorities within prescribed timelines.
👀 What to Watch
Investors should monitor the progress of the tax appeal as the ₹123.58 crore addition is significant, though the company's claim of computation errors suggests the final liability may be lower.
Mastek Receives ₹123.58 Cr Income Tax Assessment Order; Company to File Objections
Mastek Limited has received a Final Assessment Order for FY 2022-23 from the Income Tax Department, involving a total income addition of ₹123.58 crore. The order includes a transfer pricing adjustment of ₹90.95 crore and domestic tax additions of ₹32.63 crore, alongside the initiation of penalty proceedings. The company has identified several errors in the tax computation, such as the non-allowance of foreign tax credits and advance tax credits from an amalgamated subsidiary. Mastek intends to challenge the order before the Income Tax Appellate Authorities and currently expects no material financial impact.
Key Highlights
Total income addition of ₹123.58 crore for the financial year 2022-23.
Includes ₹90.95 crore in transfer pricing adjustments and ₹32.63 crore under domestic tax laws.
Income Tax Department has initiated penalty proceedings under Section 270A.
Company claims computation errors regarding tax rates and non-grant of credit for advance tax paid by an amalgamated subsidiary.
Mastek will file objections with the Income Tax Appellate Authorities within prescribed timelines.
👀 What to Watch
Investors should monitor the outcome of the appellate proceedings as the contested amount is significant. However, the company's claim of computational errors suggests potential for a favorable rectification or stay.
Mastek Appoints Amit Gajwani as COO; Succeeds Prameela Kalive
Mastek has appointed Amit Gajwani as Chief Operating Officer to drive its AI-first transformation and global operations. Gajwani brings over 28 years of experience, including a successful tenure at LTM Limited where he built the Europe business unit into a high-growth vertical. He succeeds Prameela Kalive, who will stay until June 2026 to ensure a smooth leadership transition. This move aims to strengthen Mastek's execution across its 40+ country footprint and 400+ active customer base.
Key Highlights
Amit Gajwani joins as COO with 28+ years of global leadership experience in IT services
Previously served as Head of Europe at LTM Limited, scaling the business from the ground up
Outgoing COO Prameela Kalive to remain until June 30, 2026, for a seamless transition
Mastek currently manages a workforce of nearly 5,000 employees across 40 countries
The company maintains a portfolio of 400+ active customers globally
👀 What to Watch
Investors should view this as a positive step in strengthening the leadership pipeline with a veteran known for scaling international markets. Monitor the upcoming quarterly results for any commentary on operational efficiency improvements under the new leadership.
Mastek Appoints Amit Gajwani as COO; Prameela Kalive to Superannuate
Mastek Limited has announced a leadership transition with the appointment of Mr. Amit Gajwani as the Chief Operating Officer (COO) effective May 18, 2026. Mr. Gajwani brings over 28 years of global experience, having previously led high-growth business units at LTM Limited and Cybage. He succeeds the current COO, Mrs. Prameela Kalive, who is scheduled to superannuate on June 30, 2026. The company has structured a transition period where Mrs. Kalive will facilitate the handover of responsibilities until her departure.
Key Highlights
Mr. Amit Gajwani appointed as Chief Operating Officer effective May 18, 2026
Outgoing COO Mrs. Prameela Kalive to superannuate from the company on June 30, 2026
New COO brings 28+ years of experience in driving strategy and large-scale operations
Mr. Gajwani previously delivered sustained double-digit growth as Head of Europe, UK, and Nordics at LTM Limited
Transition period established to ensure smooth handover of senior management responsibilities
👀 What to Watch
Investors should monitor the impact of the new COO on Mastek's operational efficiency and global expansion, particularly in the European markets where he has a proven track record. No immediate portfolio changes are recommended as the transition appears orderly.
Mastek to Sell Chennai SEZ Asset for Rs 60 Crore
Mastek Limited has entered into a Memorandum of Understanding (MOU) to sell its commercial building and leased land located at Mahindra World City, SEZ, Chennai. The transaction involves a built-up area of approximately 1,57,233 Sq. Ft. on 15.50 acres of land for a total consideration of Rs 60 crore. The buyer, Caresoft Mobility Private Limited, is a non-related party, and the payment will be received in two tranches. This divestment represents a monetization of real estate assets, likely aimed at improving the company's liquidity or capital allocation efficiency.
Key Highlights
Sale of commercial building with 1,57,233 Sq. Ft. built-up area on 15.50 acres of leased land.
Total aggregate consideration of Rs 60 crore to be received in two tranches.
Buyer identified as Caresoft Mobility Private Limited, confirming no related party involvement.
Asset located in Mahindra World City, SEZ, Chengalpattu, Chennai.
Transaction is subject to necessary regulatory approvals and SEZ compliances.
👀 What to Watch
Investors should view this as a positive move to unlock value from non-core assets. Watch for updates on the final sale agreement and how the company plans to utilize the Rs 60 crore cash inflow.
Mastek Q4 FY26: Revenue up 3.6% QoQ to ₹938 Cr; Order Backlog Grows 13.5% YoY to $300M
Mastek reported a stable Q4 FY26 with revenue reaching $103.5 million and a steady EBITDA margin of 16.1%. The company's 12-month order backlog grew significantly to $300.4 million, providing strong visibility for FY27 despite global macroeconomic headwinds. While the US market underwent a strategic reset, the UK business remained a major growth driver, particularly in the healthcare sector. Management declared a final dividend of ₹16 per share, bringing the total FY26 payout to ₹24 per share.
Key Highlights
12-month order backlog reached $300.4 million, representing a 13.5% YoY increase in USD terms.
Full-year FY26 revenue stood at $421.2 million, up 3.1% YoY, with EBITDA margins maintained at 15.8%.
UK & Europe business grew 21.8% in INR terms, driven by a 24% USD growth in the healthcare vertical.
Days Sales Outstanding (DSO) improved to 73 days, the lowest level recorded in the last 12 quarters.
Recognized a total exceptional impact of ₹30 crore for Labor Code changes, fully reflected in the FY26 financials.
👀 What to Watch
Investors should monitor the execution of the strong order book in H1 FY27 and the expected turnaround in the North American geography. The stock remains a steady play on UK public sector spending and AI-driven operational efficiency.
Mastek Q4 Net Profit Jumps 31% YoY to ₹106 Cr; Order Backlog Grows 24% to ₹2,849 Cr
Mastek reported a resilient Q4FY26 with revenue growing 3.6% YoY to ₹938 crore and a significant 30.9% surge in net profit to ₹106.2 crore. The company's 12-month order backlog reached a robust ₹2,849.2 crore, marking a 24.4% YoY growth, driven by strong performance in the UK and US markets. AI adoption is a key growth driver, with over 25 AI-assisted deals closed in the quarter and a 12% improvement in revenue per employee. The board has recommended a final dividend of ₹16 per share, bringing the total FY26 payout to 480%.
Key Highlights
Q4FY26 Net Profit rose 30.9% YoY to ₹106.2 crore, while Revenue from Operations grew 3.6% YoY to ₹938 crore.
12-month order backlog grew by 24.4% YoY in rupee terms to ₹2,849.2 crore ($300.4 mn).
Operating EBITDA margin remained steady at 16.1% for Q4, despite absorbing annual wage revisions.
Closed 25+ AI-assisted deals in Q4, totaling 85+ for FY26, leading to a 12% improvement in revenue per employee.
Recommended a final dividend of ₹16 per share, taking the total dividend for FY26 to 480%.
👀 What to Watch
Investors should focus on the strong 24.4% growth in the order backlog and the successful 'Lead with AI' strategy which is improving productivity. The robust cash balance of ₹938.5 crore and increased dividend payout reflect strong financial health and management confidence.
Mastek Q4FY26: PAT Jumps 30.9% Y-o-Y to ₹106.2 Cr; Order Backlog Surges 24.4%
Mastek reported a resilient Q4FY26 with revenue growing 3.6% Y-o-Y to ₹938 crore and Net Profit surging 30.9% Y-o-Y to ₹106.2 crore. A key highlight is the 12-month order backlog, which grew significantly by 24.4% Y-o-Y to ₹2,849.2 crore, providing strong revenue visibility for FY27. The company maintained an Operating EBITDA margin of 16.1% and ended the year with a robust cash balance of ₹938.5 crore. Additionally, the board recommended a final dividend of ₹16 per share, totaling 480% for the full year.
Key Highlights
Net Profit increased 30.9% Y-o-Y to ₹106.2 crore, despite a marginal 2% sequential decline.
12-month order backlog grew 24.4% Y-o-Y in rupee terms to ₹2,849.2 crore ($300.4 mn).
Operating EBITDA margin stood at 16.1% for Q4, showing resilience against wage revisions.
Strong AI adoption with 25+ new AI deals in Q4, taking the FY26 total to over 85 deals.
Proposed final dividend of ₹16 per share, resulting in a total dividend of ₹32 for FY26.
👀 What to Watch
Investors should take confidence in the 24% growth of the order backlog and the successful 'Lead with AI' strategy which is improving revenue per employee. The strong cash position and increased dividend payout suggest financial stability and a positive outlook for FY27.
Mastek Recommends Final Dividend of Rs. 16 per Share; Total FY26 Dividend at Rs. 24
Mastek Limited's Board has recommended a final dividend of Rs. 16 per equity share for the financial year ended March 31, 2026. When combined with the interim dividend of Rs. 8, the total dividend for FY 2025-26 stands at Rs. 24 per share, marking an increase from Rs. 23 in the previous year. The company also approved its annual audited financial results, which received an unmodified opinion from statutory auditors. The dividend payment is subject to shareholder approval at the upcoming 44th Annual General Meeting.
Key Highlights
Recommended final dividend of Rs. 16 per equity share (320% of face value of Rs. 5)
Total dividend for FY 2025-26 is Rs. 24 per share (480%), compared to Rs. 23 (460%) in FY 2024-25
Statutory auditors Walker Chandiok & Co LLP issued an unmodified audit opinion on financial statements
Dividend to be paid within 30 days of approval at the 44th Annual General Meeting
Financial results include the restated impact of the merger with Mastek Enterprise Solutions Private Limited
👀 What to Watch
Investors should hold for the dividend payout which reflects a steady yield and consistent payout policy. Monitor the upcoming announcement regarding the record date to ensure eligibility for the final dividend.
Mastek Recommends Final Dividend of Rs 16; Total FY26 Dividend Rises to Rs 24 Per Share
Mastek Limited has approved its annual audited financial results for the fiscal year ended March 31, 2026. The Board recommended a final dividend of Rs 16 per share (320% of face value), bringing the total dividend for FY26 to Rs 24 per share, up from Rs 23 in the previous year. The statutory auditors issued an unmodified opinion on both standalone and consolidated results. The financials also account for the merger with its wholly-owned subsidiary, Mastek Enterprise Solutions, which was effective from April 1, 2024.
Key Highlights
Recommended a final dividend of Rs 16 per share (320% on face value of Rs 5)
Total dividend for FY 2025-26 stands at Rs 24 per share (480%) versus Rs 23 in FY 2024-25
Statutory auditors Walker Chandiok & Co LLP issued an unmodified audit opinion
Financial results restated from April 1, 2024, following the merger with Mastek Enterprise Solutions
Final dividend is subject to shareholder approval at the 44th Annual General Meeting
👀 What to Watch
Investors should view the marginal increase in total dividend as a sign of stable cash flow and shareholder commitment. Monitor the detailed P&L and balance sheet figures once the full annual report is released to assess underlying growth.
